Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation
Crossref DOI link: https://doi.org/10.1186/s13000-016-0458-6
Published Online: 2016-02-09
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bae, Ja Seong
Kim, Yourha
Jeon, Sora
Kim, Se Hee
Kim, Tae Jung
Lee, Sohee
Kim, Min-Hee
Lim, Dong Jun
Lee, Youn Soo
Jung, Chan Kwon
Funding for this research was provided by:
National Research Foundation of Korea (KR) (2013R1A2A2A01068570)